Yongqian Shu
Molecular Biology · 2010–2019
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 78 citations into it
- Cancer Research — 44 citations into it
Whom Yongqian Shu trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- G. Semenza (in Cancer Research)
Papers from Yongqian Shu's perspective
Ordered by how strongly the researchers Yongqian Shu trusts endorse each paper. Same corpus, a different order for every researcher.
- Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival (Cancer Research)
- Hypoxia — a key regulatory factor in tumour growth (Nature Reviews. Cancer)
- Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. (Cancer Cell)
- MicroRNA signatures in human cancers (Nature Reviews. Cancer)
- MicroRNA expression profiles classify human cancers (Nature)
- A five-gene signature and clinical outcome in non-small-cell lung cancer. (New England Journal of Medicine)
- HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. (Cell)
- Targeting HIF-1 for cancer therapy (Nature Reviews. Cancer)
- Hypoxia-inducible factors and the response to hypoxic stress. (Molecules and Cells)
- Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis (Molecular and Cellular Biology)
Their papers
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment (2019) — 1,623 citations
- Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. (2010) — 809 citations
- Pyroptosis: A new frontier in cancer. (2019) — 878 citations